1. Home
  2. ADAP vs AGMH Comparison

ADAP vs AGMH Comparison

Compare ADAP & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • AGMH
  • Stock Information
  • Founded
  • ADAP 2008
  • AGMH 2015
  • Country
  • ADAP United Kingdom
  • AGMH Hong Kong
  • Employees
  • ADAP N/A
  • AGMH N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • ADAP Health Care
  • AGMH Technology
  • Exchange
  • ADAP Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • ADAP 21.3M
  • AGMH 17.1M
  • IPO Year
  • ADAP 2015
  • AGMH 2018
  • Fundamental
  • Price
  • ADAP $0.08
  • AGMH $4.04
  • Analyst Decision
  • ADAP Hold
  • AGMH
  • Analyst Count
  • ADAP 6
  • AGMH 0
  • Target Price
  • ADAP $1.02
  • AGMH N/A
  • AVG Volume (30 Days)
  • ADAP 106.3M
  • AGMH 251.9K
  • Earning Date
  • ADAP 11-12-2025
  • AGMH 11-18-2025
  • Dividend Yield
  • ADAP N/A
  • AGMH N/A
  • EPS Growth
  • ADAP N/A
  • AGMH N/A
  • EPS
  • ADAP N/A
  • AGMH 16.43
  • Revenue
  • ADAP $65,084,999.00
  • AGMH $48,526,743.00
  • Revenue This Year
  • ADAP N/A
  • AGMH N/A
  • Revenue Next Year
  • ADAP $24.70
  • AGMH N/A
  • P/E Ratio
  • ADAP N/A
  • AGMH $0.22
  • Revenue Growth
  • ADAP N/A
  • AGMH 18.80
  • 52 Week Low
  • ADAP $0.04
  • AGMH $1.09
  • 52 Week High
  • ADAP $0.86
  • AGMH $99.47
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 41.40
  • AGMH 38.72
  • Support Level
  • ADAP $0.04
  • AGMH $4.41
  • Resistance Level
  • ADAP $0.24
  • AGMH $5.17
  • Average True Range (ATR)
  • ADAP 0.04
  • AGMH 0.54
  • MACD
  • ADAP -0.01
  • AGMH -0.45
  • Stochastic Oscillator
  • ADAP 15.65
  • AGMH 6.93

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: